Is there more than C-reactive protein and fibrinogen? The prognostic value of soluble CD40 ligand, interleukin-6 and oxidized low-density lipoprotein with respect to coronary and cerebral vascular disease.
about
CD40 ligand as a potential biomarker for atherosclerotic instabilityLong-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic reviewThe relationship between heart rate variability and inflammatory markers in cardiovascular diseases.Acute suppression of circulating sCD40L during hyperglycemia and euglycemic-hyperinsulinemia in healthy young males.Modified low density lipoprotein and lipoprotein-containing circulating immune complexes as diagnostic and prognostic biomarkers of atherosclerosis and type 1 diabetes macrovascular disease.Atherosclerosis in type 2 diabetes: a role for fibrate therapy?Lipopolysaccharide regulated protein expression is only partly impaired in monocytes from patients with type I diabetes.Heart rate variability and biomarkers of systemic inflammation in patients with stable coronary heart disease: findings from the Heart and Soul StudyRelationship between heart rate variability, interleukin-6, and soluble tissue factor in healthy subjects.Significant association between serum interleukin-6 and Helicobacter pylori antibody levels among H. pylori-positive Japanese adults.CD40-CD40L: linking pancreatic, adipose tissue and vascular inflammation in type 2 diabetes and its complications.Thiamylal sodium increased inflammation and the proliferation of vascular smooth muscle cells.CD40 ligand shedding is regulated by interaction between matrix metalloproteinase-2 and platelet integrin alpha(IIb)beta(3).Resveratrol attenuates angiotensin II-induced interleukin-6 expression and perivascular fibrosis.Hass avocado modulates postprandial vascular reactivity and postprandial inflammatory responses to a hamburger meal in healthy volunteers.Therapeutic dosages of oral or transdermal estradiol did not modify sCD40L levels in postmenopausal women.The relationship between soluble CD40 ligand level and atherosclerosis in white-coat hypertension.CD40-1C>T polymorphism (rs1883832) is associated with brain vessel reocclusion after fibrinolysis in ischemic stroke.Acute phase proteins and oxidised low-density lipoprotein in association with ischemic stroke subtype, severity and outcome.Effects of PM2.5 collected from Cache Valley Utah on genes associated with the inflammatory response in human lung cells.Effect of interleukin-6 receptor blockage on renal injury in apolipoprotein E-deficient mice
P2860
Q28288474-198E5632-B09D-4940-8BBC-3D51CB971268Q28755180-6F6461E5-ABCF-42D2-8666-CA97DC635C28Q33372271-25121D19-9364-46C4-91AA-22B6D8198EEBQ33768652-35927778-AD5D-4DDD-A4F0-045C17EA49DDQ34072528-14CF5EC8-1BE8-4191-8D38-D42F98444A6AQ34730108-2DD5206B-57FD-4F76-98F9-ABC2E5E9E7A0Q34880667-A0D175D3-64D7-4B77-8BCE-441D8EBE361CQ35521706-D3F7EF39-B494-4956-8103-F52FAF048B92Q36639373-E9076F7E-06A8-46F1-A148-8133D8026C61Q37436503-04F6C93E-094C-4508-9C0A-638E21B9DF78Q38042321-8134E960-C9EA-4AB9-A3F4-14934AEE49BCQ41971062-49C8A9F6-920D-4916-BBEE-FBCFC650CAA1Q43129374-1C2DDF04-DEA6-4E93-BF66-3644CD98C65EQ46047730-0343C58A-B3EF-4B07-B3DD-02E7A820CF0FQ46095359-3FAC6CE1-FC79-4B94-815E-8B06FF9412D3Q46515511-328EA155-BFB1-4451-90BD-7274764CA52BQ47432887-ECF9155A-9453-45A6-9315-26BF1E436629Q48185202-38E51049-B274-4032-A271-A243D4AB5BD3Q48238916-0CB59AF2-DF91-4956-87A0-674DC165BED6Q53526231-65C7B3C4-F4EC-4E90-9A04-E64A72B502D0Q58363469-6F26C4AE-7B29-4013-9E4F-9C5C63AF4442
P2860
Is there more than C-reactive protein and fibrinogen? The prognostic value of soluble CD40 ligand, interleukin-6 and oxidized low-density lipoprotein with respect to coronary and cerebral vascular disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Is there more than C-reactive ...... and cerebral vascular disease.
@ast
Is there more than C-reactive ...... and cerebral vascular disease.
@en
type
label
Is there more than C-reactive ...... and cerebral vascular disease.
@ast
Is there more than C-reactive ...... and cerebral vascular disease.
@en
prefLabel
Is there more than C-reactive ...... and cerebral vascular disease.
@ast
Is there more than C-reactive ...... and cerebral vascular disease.
@en
P2093
P1433
P1476
Is there more than C-reactive ...... and cerebral vascular disease
@en
P2093
Cleutjens KB
Heeneman S
Nelemans PJ
van Engelshoven JM
P356
10.1016/J.ATHEROSCLEROSIS.2005.11.005
P577
2005-12-19T00:00:00Z